
SentiSense
Ctrl+K
Quick tip: Press
to search stocks
D
DGX
Quest Diagnostics Incorporated
$199.70
-1.18 (-0.59%)
Summary
Stories
News
Metrics
Fundamentals
Holders
Full institutional holders data is a Pro feature
UpgradeInstitutional Holders
976
tracked filers
Total Institutional Value
$8.6B
976 holders tracked
Report Date
Q4 2025
SEC 13F-HR filing
Notable changes (1)
| Holder | Category | Shares | Value | Weight | Change |
|---|---|---|---|---|---|
PRICE T ROWE ASSOCIATES INC /MD/ | Other | 6.8M | $1.3M | -- | -2.7% |
STATE STREET CORP | Index Fund | 5.2M | $995.6M | -- | +0.8% |
GEODE CAPITAL MANAGEMENT, LLC | Index Fund | 2.7M | $514.4M | -- | +1.6% |
VICTORY CAPITAL MANAGEMENT INC | Other | 2.2M | $425.8M | -- | -16.1% |
Grantham, Mayo, Van Otterloo & Co. LLC | Other | 1.7M | $332.8M | -- | -0.1% |
Data source: SEC EDGAR 13F-HR filings
Company Profile
Symbol
DGX
Market Cap
$22.07B
IPO Date
Dec 17, 1996
CEO
--
Employees
57,000
Sector
--
Industry
SERVICES-MEDICAL LABORATORIES
Country
United States
Exchange
--
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Read MoreSimilar Stocks
LH
LabCorp Holdings Inc.
$263.80
+0.34%
ABT
Abbott Laboratories
$108.03
-0.10%